PD-RX Pharmaceuticals

PDRX · OTC

$3.10+$3.10 (+0.00%)TodayMarket closed ·
No price history for this range.

About PDRX

PD-Rx Pharmaceuticals, Inc. engages in the pharmaceutical services business. The company is headquartered in Oklahoma City, Oklahoma. The company went IPO on 2001-12-17. The firm has a complete line of pharmaceutical repackaging for physician dispensing as well as Web-based software to manage point-of-care dispensing. Its software solution tailored to physicians who want to add or enhance their medication dispensing capabilities. The Company’s services cater to multiple specialties, including primary care, urgent care, pain management, occupational medicine, orthopedic medicine, bariatric care, and dental practices. Its automated production line produces approximately 2,000 bottles per hour. The firm can develop private labels for repackaged pharmaceuticals and also duplicate the current design or create new artwork. The company has point of care programs for all types of orthopedic practices, such as outpatient surgery, outpatient care and workers compensation.

Employees
0
Headquarters
Oklahoma City, Oklahoma
Listed
Dec 17, 2001
Sector
Health Care
Industry
Health Care Providers & Services
Website
pdrx.com

PDRX key statistics

Market cap
4.79M
Price-earnings ratio
—
Dividend yield
—
Average volume
870
Volume
500
Open price
$3.10
High today
$3.10
Low today
$3.10
52 Week high
$3.35
52 Week low
$2.75

PD-RX Pharmaceuticals (PDRX) at a glance

As of Sep 16, 2026, PD-RX Pharmaceuticals (PDRX) shares are priced at $3.10, giving the company a market cap of 4.79M.

Volume so far is 500 shares, below the average of 870 shares a day.

Over the past year PD-RX Pharmaceuticals has ranged from $2.75 to $3.35, and now sits 58% of the way up that range.

Similar companies

Companies in the same industry as PD-RX Pharmaceuticals

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.